Riskpilot← Back to searchSign inGet full accessMedix Biochemica Group Oy
OYActiveY-tunnus 2883809-1Klovinpellontie 3Business and other management consultancy activities · NACE 7020Est. 20182 employees
Revenue 2024
EUR 71,9M
EBITDA margin
22.2%
Equity ratio
—
Financial strength
Net profit 2024
EUR -15,6M
2 employees
| Revenue | EUR 71,9M | — |
| EBITDA | EUR 16M | — |
| Net profit | EUR -15,6M | — |
| Total assets | EUR 0 | -100% |
| Equity | EUR 4,8M | -92% |
| Employees | 2 | — |
Legal name
Medix Biochemica Group Oy
Y-tunnus number
2883809-1
Legal form
Osakeyhtiö
NACE code
7020 · Business and other management consultancy activities
Founded
15. tammikuuta 2018
Share capital
EUR 2 500
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on omistaa ja kehittää koti- ja ulkomaisia yhtiöitä, omistaa ja hallita osakkeita, osuuksia, korkoinstrumentteja ja muita oman tai vieraan pääoman ehtoisia arvopapereita sekä käydä kauppaa niillä. Toimintaansa yhtiö voi harjoittaa joko suoraan tai tytär- ja osakkuusyhtiöitä sekä muita yhtiöitä käyttäen.
Address
Klovinpellontie 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 186 | 1 671 | 769 | 0 | 71 880 |
| Staff expenses | −1 503 | −1 421 | −717 | −0 | −28 197 |
| EBITDA | −104 | −240 | −305 | 0 | 15 963 |
| Depreciation & amort. | — | — | — | −0 | −20 526 |
| EBIT | −104 | −240 | −305 | 0 | −4 563 |
| Net financials | 210 | 389 | 7 028 | 0 | −12 763 |
| Profit before tax | 106 | 75 | 6 723 | 0 | −17 326 |
| Tax | 6 | 15 | −0 | −0 | −1 708 |
| Net profit | 99 | 60 | 6 723 | 0 | −15 618 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 82 135 | 97 661 | 63 568 | 63 473 | 0 |
| Equity | 58 480 | 57 419 | 63 126 | 62 896 | 4 758 |
| Long-term debt | 21 250 | 32 000 | — | 152 967 | 152 967 |
| Short-term debt | 2 406 | 8 242 | 443 | 21 193 | 15 697 |
| Total debt | 23 656 | 40 242 | 443 | 174 160 | 168 664 |
EBITDA margin
22.2%
This company
15.8%
Market median
+41% vs market
20202024
Equity ratio
475757900.0%
This company
38.2%
Market median
+1245439429% vs market
20202024
Return on equity
-328.3%
This company
18.4%
Market median
-1884% vs market
20202024
Net profit margin
-21.7%
This company
8.1%
Market median
-368% vs market
20202024
Asset turnover
71879711.00×
This company
1.12×
Market median
+6417831239% vs market
20202024
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TM Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (3) | ||
SR Chief Executive Officer | Chief Executive Officer | 2020 – 2025 |
HJ | Audit | 2018 – 2022 |
PA | Audit | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2022 | |
| Chairperson | 2018 | |
| Board of Directors | 2022 | |
| Board of Directors | 2018 | |
| Former (4) | ||
| Board of Directors | 2019 – 2022 | |
| Board of Directors | 2018 – 2023 | |
| Board of Directors | 2018 – 2019 | |
| Board of Directors | 2018 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 76.3% | 76.3% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DevCo Partners OyDevCo HoldCo 2 Oy
Medix Biochemica Group Oy (this company)Shanghai Medix Medical Technology Co. Ltd, KiinaBioresource Technology LLC, YhdysvallatMedix Biochemica USA Inc., YhdysvallatViroStat LLC, YhdysvallatmyPOLS Biotec GmbH, SaksaBoard members of Medix Biochemica Group Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stephen Ronan Ferguson | Chief Executive Officer | 0 companies |
| Heikki Juhani Lassila | Audit | 0 companies |
| Pasi Antero Karppinen | Audit | 0 companies |
| Teemu Matias Alahuhta | Chief Executive Officer | 0 companies |
| Juhani Ville Ilmari Laakso | Board of Directors | 0 companies |
| Lonnie Rebecca Shoff | Board of Directors | 0 companies |
| Mikko Matias Karioja | Board of Directors | 0 companies |
| Ann-Christine Margareta Sundell | Chairperson | 0 companies |
| Timo Mika Juhani Ahopelto | Board of Directors | 0 companies |
| Otto Lauri Julius Kukkonen | Board of Directors | 0 companies |
| Michele Pedrocchi | Board of Directors | 0 companies |
| Kerttu Maria Tuomas | Board of Directors | 0 companies |
| Pekka Allan Antero Mattila | Board of Directors | 0 companies |